![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 50, 48333-48341, December 13, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
, and
§¶
From the The exposure of collagen fibers at sites of
vascular injury results in the adherence of platelets and their
subsequent activation. The platelet collagen receptor glycoprotein
(GP)1 VI plays a crucial role in platelet activation
and thrombus formation and decreased levels or defective GPVI may lead
to excessive bleeding. In addition, elevated levels of collagen
receptors may predispose individuals to coronary heart disease or
strokes. GPVI expression is restricted to platelets and their precursor
cell, the megakaryocyte. In this study we investigate the
regulation of GPVI expression and show that thrombopoietin induces its
expression in the megakaryocytic cell line UT-7/TPO. A 5'-region
flanking the transcription start point of the GPVI gene was
cloned (
Centre for Thrombosis and Vascular Research,
and § Department of Medicine, St. George Clinical School,
University of New South Wales,
Sydney, New South Wales 2052, Australia
694 to +29) and we report that this putative GPVI
promoter bestows megakaryocye-specific expression. Deletion analyses
and site-directed mutagenesis identified Sp1227,
GATA177, and Ets48 sites as essential for
GPVI expression. We show that transcription factors GATA-1,
Fli-1, and Sp1 can bind to and activate this promoter. Finally, GPVI
mRNA was detected only in megakaryocytic cell lines expressing both
Fli-1 and GATA-1, and we show that overexpression of Fli-1 in a stable
cell line (which expresses endogenous GATA-1 and Sp1) results in
expression of the endogenous GPVI gene.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF521646.
¶ To whom correspondence should be addressed. Present address: Dept. of Medicine, St. George Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia. Tel.: 61-2-9350-2010; Fax: 61-2-9350-3998; E-mail: b.h.chong@unsw.edu.au.This article has been cited by other articles:
![]() |
Y. Hazony, J. Lu, C. St. Hilaire, and K. Ravid Hematopoietic gene promoters subjected to a group-combinatorial study of DNA samples: identification of a megakaryocytic selective DNA signature Nucleic Acids Res., September 11, 2006; 34(16): 4416 - 4428. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohmori, J. Mimuro, K. Takano, S. Madoiwa, Y. Kashiwakura, A. Ishiwata, M. Niimura, K. Mitomo, T. Tabata, M. Hasegawa, et al. Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ib{alpha} promoter: in vivo model for platelet-targeting gene therapy FASEB J, July 1, 2006; 20(9): 1522 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fang, K. Hodivala-Dilke, B. D. Johnson, L. M. Du, R. O. Hynes, G. C. White II, and D. A. Wilcox Therapeutic expression of the platelet-specific integrin, {alpha}IIb{beta}3, in a murine model for Glanzmann thrombasthenia Blood, October 15, 2005; 106(8): 2671 - 2679. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Hughan, Y. Senis, D. Best, A. Thomas, J. Frampton, P. Vyas, and S. P. Watson Selective impairment of platelet activation to collagen in the absence of GATA1 Blood, June 1, 2005; 105(11): 4369 - 4376. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kanaji, T. Kanaji, B. Jacquelin, M. Chang, D. J. Nugent, N. Komatsu, M. Moroi, K. Izuhara, and T. J. Kunicki Thrombopoietin initiates demethylation-based transcription of GP6 during megakaryocyte differentiation Blood, May 15, 2005; 105(10): 3888 - 3892. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hu, A. S. Philips, J. C. Kwok, M. Eisbacher, and B. H. Chong Identification of Nuclear Import and Export Signals within Fli-1: Roles of the Nuclear Import Signals in Fli-1-Dependent Activation of Megakaryocyte-Specific Promoters Mol. Cell. Biol., April 15, 2005; 25(8): 3087 - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Masuya, O. Moussa, T. Abe, T. Deguchi, T. Higuchi, Y. Ebihara, D. D. Spyropoulos, D. K. Watson, and M. Ogawa Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice Blood, January 1, 2005; 105(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jackers, G. Szalai, O. Moussa, and D. K. Watson Ets-dependent Regulation of Target Gene Expression during Megakaryopoiesis J. Biol. Chem., December 10, 2004; 279(50): 52183 - 52190. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gottgens, C. Broccardo, M.-J. Sanchez, S. Deveaux, G. Murphy, J. R. Gothert, E. Kotsopoulou, S. Kinston, L. Delaney, S. Piltz, et al. The scl +18/19 Stem Cell Enhancer Is Not Required for Hematopoiesis: Identification of a 5' Bifunctional Hematopoietic-Endothelial Enhancer Bound by Fli-1 and Elf-1 Mol. Cell. Biol., March 1, 2004; 24(5): 1870 - 1883. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |